Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1–2, open-label, multicohort trial

Ana Oaknin, Kathleen N. Moore, Tim Meyer, José López-Picazo González, Lot A. Devriese, Asim Amin, Christopher D. Lao, Valentina Boni, William H. Sharfman, Jong Chul Park, Makoto Tahara, Suzanne L. Topalian, Manuel Magallanes, Alejandro Molina Alavez, Tariq Aziz Khan, Catherine Copigneaux, Michelle Lee, Charlie Garnett‐Benson, Xuya Wang, R. Wendel Naumann